Zydus receives final approval from US FDA for Ivermectin cream
The cream is used for the treatment of inflammatory lesions of rosacea
Zydus Lifesciences has received final approval from the US Food and Drug Administration (FDA) to market Ivermectin cream, 1%, according to a company statement.
The statement informed that Ivermectin cream is used for the treatment of inflammatory lesions of rosacea. The drug will be manufactured at the group’s topical manufacturing facility at Ahmedabad, India.